medicine and life sciences

Life Sciences - Sep 24
Life Sciences
For more than a century, the Nissle 1917 strain of the bacterium Escherichia coli has been used as a probiotic to treat gastrointestinal disorders. However, this bacterium also produces a toxin, colibactin, which has deleterious effects on host DNA and might cause colon cancer. It is therefore crucial to understand the mechanisms at play in the strain if we wish to limit undesirable side effects.
Environment - Jul 29
Environment

Scientists from INRA, CEA, CNRS, CNES and several international universities 1 have quantified - over the 2010-2017 period ' the time changes in the carbon stocks of aboveground vegetation biomass in the tropics.

Life Sciences - Jul 18
Life Sciences

Prebiotics are currently a preferred treatment for certain metabolic disorders, as they can restore the balance of dysfunctional gut microbiota, and improve the body's metabolism.

Life Sciences - Jul 25
Life Sciences

INRA researchers, in collaboration with the University of Adelaide, Australia, studied the effects that a widely used artificial sweetener blend, i.e. acesulfame K-sucralose, has on metabolism.

Environment - Jun 13
Environment

To produce a significant reduction in mortality due to fine particulates, their average level should be reduced by at least 3 micrograms per m3 as a yearly average, concludes an interdisciplinary s


This site uses cookies and analysis tools to improve the usability of the site. More information. |